Jean-Yves WINUM de l’IBMM, co-éditeur avec le Pr. Claudiu SUPURAN de l’Université de Florence
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications
See online : http://eu.wiley.com/WileyCDA/WileyT...
The book gives students and young researchers a resource on zinc enzymes, some of which were intensively studied for more than six decades and translated into model success stories of the pharmaceutical industry. Up-to-date overviews on the major drug targets of the field are presented, showing the structural basis for catalysis, binding of inhibitors and activators, and their clinical applications. Emergent roles of some recently discovered isozymes in cancer, obesity, epilepsy, pain management, and malaria are also introduced, together with the most recent achievements in drug design from both academia and industry. A voir dans la lettre hebdo du CNRS : http://www.cnrs.fr/languedoc-roussi… ainsi que sur le site web de la Délégation CNRS DR13 : http://www.cnrs.fr/languedoc-roussi…
See online : http://eu.wiley.com/WileyCDA/WileyT...
All the versions of this article: [English] [français]
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications - 517.4 kb |
In the same section :
- Drug Design of Zinc-Enzyme Inhibitors : Functional, Structural, and Disease Applications
- Hot Article : borono-analogues of nucleotides (16 September 2009)
- Solvent-free Peptide Synthesis
- COLCOM, the NANO-MATERIALS L-Lysine, DGL specifically designed for applications in the field of health, diagnostic, textile, filter,…
- Download the New Computer Program to facilitate the Identification of modified PEG’s by Mass Spectrometry.
